Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.13 (
aldolase
)
3,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The macrophage protein tyrosine phosphatase-1
SHP-1
has been implicated in the pathogenesis of infection with leishmania. To identify the factors that may interact with
SHP-1
, Leishmania donovani promastigote lysates were added to a GST-
SHP-1
affinity matrix. A 44kDa specifically bound protein was identified as leishmania fructose-1,6-bisphosphate
aldolase
(
aldolase
). Purified leishmania
aldolase
bound to
SHP-1
indicating that the interaction was direct. In contrast, purified mammalian
aldolase
did not bind to
SHP-1
. Consistent with this, leishmania
aldolase
activated
SHP-1
in vitro, whereas mammalian
aldolase
did not. The presence of leishmania
aldolase
in the cytosolic fractions prepared from infected macrophages indicated that leishmania
aldolase
is exported from phagolysosomes in infected cells where it can target host cytosolic proteins. In fact, co-immunoprecipitation showed association of leishmania
aldolase
with
SHP-1
. Moreover, leishmania
aldolase
-expressing macrophages showed the deactivated phenotype of leishmania infected cells as judged by much reduced inability to induce expression of nitric-oxide synthase in response to interferon-gamma treatment. Collectively, these data show that leishmania
aldolase
is a novel
SHP-1
binding and activating protein that contributes to macrophage dysfunction.
...
PMID:Identification of leishmania fructose-1,6-bisphosphate aldolase as a novel activator of host macrophage Src homology 2 domain containing protein tyrosine phosphatase SHP-1. 1802 78